380 related articles for article (PubMed ID: 21129377)
1. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.
Vasen HF; Wasser M; van Mil A; Tollenaar RA; Konstantinovski M; Gruis NA; Bergman W; Hes FJ; Hommes DW; Offerhaus GJ; Morreau H; Bonsing BA; de Vos tot Nederveen Cappel WH
Gastroenterology; 2011 Mar; 140(3):850-6. PubMed ID: 21129377
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer surveillance: learning as we go.
Brentnall TA
Am J Gastroenterol; 2011 May; 106(5):955-6. PubMed ID: 21540900
[TBL] [Abstract][Full Text] [Related]
3. Variation in precursor lesions of pancreatic cancer among high-risk groups.
Potjer TP; Schot I; Langer P; Heverhagen JT; Wasser MN; Slater EP; Klöppel G; Morreau HM; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bargello M; Gress TM; Vasen HF; Bartsch DK; ;
Clin Cancer Res; 2013 Jan; 19(2):442-9. PubMed ID: 23172884
[TBL] [Abstract][Full Text] [Related]
4. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients: the place of endoscopic ultrasound].
Béchade D
Presse Med; 2011 Mar; 40(3):230-8. PubMed ID: 21211938
[TBL] [Abstract][Full Text] [Related]
5. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
[No Abstract] [Full Text] [Related]
6. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.
Del Chiaro M; Verbeke CS; Kartalis N; Pozzi Mucelli R; Gustafsson P; Hansson J; Haas SL; Segersvärd R; Andren-Sandberg Å; Löhr JM
JAMA Surg; 2015 Jun; 150(6):512-8. PubMed ID: 25853369
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
de vos tot Nederveen Cappel WH; Offerhaus GJ; van Puijenbroek M; Caspers E; Gruis NA; De Snoo FA; Lamers CB; Griffioen G; Bergman W; Vasen HF; Morreau H
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3598-605. PubMed ID: 14506146
[TBL] [Abstract][Full Text] [Related]
8. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients].
Béchade D
Bull Cancer; 2011 Jul; 98(7):827-36. PubMed ID: 21684836
[TBL] [Abstract][Full Text] [Related]
9. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
[TBL] [Abstract][Full Text] [Related]
10. Screening and surgical outcomes of familial pancreatic cancer.
Templeton AW; Brentnall TA
Surg Clin North Am; 2013 Jun; 93(3):629-45. PubMed ID: 23632149
[TBL] [Abstract][Full Text] [Related]
11. Imaging of pancreatic adenocarcinoma: update on staging/resectability.
Tamm EP; Balachandran A; Bhosale PR; Katz MH; Fleming JB; Lee JH; Varadhachary GR
Radiol Clin North Am; 2012 May; 50(3):407-28. PubMed ID: 22560689
[TBL] [Abstract][Full Text] [Related]
12. Poorly enhanced areas of pancreatic adenocarcinomas on late-phase dynamic computed tomography: comparison with pathological findings.
Hattori Y; Gabata T; Zen Y; Mochizuki K; Kitagawa H; Matsui O
Pancreas; 2010 Nov; 39(8):1263-70. PubMed ID: 20467344
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathology of early pancreatic cancer.
Remmers N; Bailey JM; Mohr AM; Hollingsworth MA
Cancer Biomark; 2010; 9(1-6):421-40. PubMed ID: 22112488
[TBL] [Abstract][Full Text] [Related]
14. Use of breast MRI surveillance in women at high risk for breast cancer: a single-institutional experience.
Elmore L; Margenthaler JA
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():263-7. PubMed ID: 20853044
[TBL] [Abstract][Full Text] [Related]
15. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing early-stage pancreatic cancer patients from disease-free individuals using serum profiling.
Hocker JR; Lerner MR; Mitchell SL; Lightfoot SA; Lander TJ; Quillet AA; Hanas RJ; Peyton MD; Postier RG; Brackett DJ; Hanas JS
Cancer Invest; 2011 Feb; 29(2):173-9. PubMed ID: 21261478
[TBL] [Abstract][Full Text] [Related]
17. Is endoscopic ultrasound "sound" for pancreatic cancer screening?
Bhutani MS; Verma D; Guha S; Lee JH; Richards-Kortum RR; Fleming JB
J Clin Gastroenterol; 2009 Oct; 43(9):797-802. PubMed ID: 19652621
[No Abstract] [Full Text] [Related]
18. Diagnosis and treatment of pancreatic and ampullary cancer.
Murr MM; Oishi AJ; Toma TP; Sarr MG
J Med Liban; 1995; 43(4):200-7. PubMed ID: 8885553
[No Abstract] [Full Text] [Related]
19. Screening and surveillance approaches in familial pancreatic cancer.
Canto MI
Gastrointest Endosc Clin N Am; 2008 Jul; 18(3):535-53, x. PubMed ID: 18674702
[TBL] [Abstract][Full Text] [Related]
20. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
Lal G; Liu L; Hogg D; Lassam NJ; Redston MS; Gallinger S
Genes Chromosomes Cancer; 2000 Apr; 27(4):358-61. PubMed ID: 10719365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]